Faes Farma, S.A. (BME:FAE)

27.29% (1Y)

Market Cap	1.39B
Revenue (ttm)	524.02M
Net Income (ttm)	109.27M
Shares Out	311.25M
EPS (ttm)	0.35
PE Ratio	12.78
Forward PE	15.79
Dividend	0.16 (3.47%)
Ex-Dividend Date	Jul 3, 2025

Volume	26,390
Average Volume	236,261
Open	4.455
Previous Close	4.480
Day's Range	4.440 - 4.480
52-Week Range	3.270 - 4.730
Beta	0.32
RSI	60.11
Earnings Date	Jul 28, 2025

About Faes Farma

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide. It operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It offers products for various therapeutic areas. The company also provides animal nutrition and health products. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1933
• Employees: 1,775
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: FAE

Financial Performance

In 2024, Faes Farma's revenue was 510.04 million, an increase of 7.81% compared to the previous year's 473.09 million. Earnings were 111.36 million, an increase of 21.17%.